TrialClinical and translational science2026

The Effect of Efavirenz and Rufinamide on the Pharmacokinetics and Safety of Quizartinib: Two Phase 1 Studies in Healthy Participants.

YoungJun Yoo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.